Difficulty: Medium
Average Score: 80%
Practice
A 32-year-old woman found out 1 month ago that she has HIV disease. She began a HAART regimen after learning her HIV status. Now she presents with nausea, vomiting, and abdominal pain. Serum amylase is elevated. If her condition is related to her medications, which drug is most likely the cause of her symptoms?
Correct answer
D
Rationale
The correct answer is D) Ritonavir. Ritonavir is a protease inhibitor commonly used in HAART regimens for HIV treatment. One of the known side effects of ritonavir is pancreatitis, which can manifest as symptoms like nausea, vomiting, and abdominal pain, along with elevated serum amylase levels. These symptoms align with the patient's presentation, indicating that ritonavir is the likely culprit.
A) Efavirenz is a non-nucleoside reverse transcriptase inhibitor commonly used in HAART regimens. While it can cause central nervous system side effects like vivid dreams, it is not typically associated with pancreatitis.
B) Emtricitabine is a nucleoside reverse transcriptase inhibitor that is generally well-tolerated and not known to cause pancreatitis.
C) Nevirapine is another non-nucleoside reverse transcriptase inhibitor used in HAART regimens. While it can cause liver toxicity, it is not a common cause of pancreatitis.
Educationally, understanding the side effect profiles of different antiretroviral medications is crucial for healthcare providers managing HIV patients. Recognizing drug-induced pancreatitis early is important for prompt management and avoiding complications in patients on HAART regimens. This case highlights the need for thorough knowledge of medication side effects to provide optimal patient care.
A) Efavirenz is a non-nucleoside reverse transcriptase inhibitor commonly used in HAART regimens. While it can cause central nervous system side effects like vivid dreams, it is not typically associated with pancreatitis.
B) Emtricitabine is a nucleoside reverse transcriptase inhibitor that is generally well-tolerated and not known to cause pancreatitis.
C) Nevirapine is another non-nucleoside reverse transcriptase inhibitor used in HAART regimens. While it can cause liver toxicity, it is not a common cause of pancreatitis.
Educationally, understanding the side effect profiles of different antiretroviral medications is crucial for healthcare providers managing HIV patients. Recognizing drug-induced pancreatitis early is important for prompt management and avoiding complications in patients on HAART regimens. This case highlights the need for thorough knowledge of medication side effects to provide optimal patient care.